Licensed Practical Nurse in Fairfield, IL Accepting Medicare

9 Licensed Practical Nurse nurses found. Showing 1 - 9

Rachel Dee Jones, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470

Katherine Violet Walker, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470

Marylouise Mae Curtis, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470

Ashten Taylor, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470

Jala Beth Taylor, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470

Melissa A. Simpson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470

Christina M Copeland, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470

Stacey L. Puntney, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470

Melissa D. Gibbs, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470

News Archive

Scientists identify signals that regulate the formation of spinal marrow

A team of researchers at Umea University in Sweden under the leadership of Thomas Edlund, Umea Center for Molecular Medicine, is now publishing their discovery of the signal molecules that regulate the formation of spinal marrow during the fetal period.

New research demonstrates brain's remarkable capacity to repair itself

New research released today demonstrates the brain's remarkable capacity to repair itself. The animal studies, which propose ways to prevent or limit damage after blood and oxygen deprivation and blood clots, were presented at Neuroscience 2011, the Society for Neuroscience's annual meeting and the world's largest source of emerging news about brain science and health.

AHRQ selects Outcome Sciences to study effects of different treatments for open angle glaucoma

Outcome Sciences, Inc. (OUTCOME), the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, today announced that the Agency for Healthcare Research and Quality (AHRQ) has selected Outcome as the DEcIDE Center for a study designed to compare the effectiveness of medications versus surgery for the treatment of open-angle glaucoma. The study will enroll 2,600 patients from 30 sites across the United States and is intended to provide new scientific information about the effects of different treatment approaches in individuals who have glaucoma.

OncoGenex completes enrollment in OGX-427 Phase 2 trial for treatment of metastatic bladder cancer

OncoGenex Pharmaceuticals, Inc. today announced that enrollment has been completed in Borealis-1, a company-sponsored, randomized, placebo-controlled Phase 2 trial of OGX-427 in combination with first-line gemcitabine and cisplatin in patients with metastatic bladder cancer.

Researchers provide insights into how phages exhibit high level of precision in cell destruction

Phage therapy, which exploits the ability of certain viruses to infect and replicate within bacteria, shows promise for treating antibiotic-resistant bacterial infections.

Read more Medical News

› Verified 4 days ago